These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10344921)

  • 21. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upper gastro-intestinal disease in Scotland: a survey of practice amongst Scottish gastroenterologists.
    Kubba AK; Whyman MR
    J R Coll Surg Edinb; 1996 Oct; 41(5):302-6. PubMed ID: 8908952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trial: evaluation of a clinical decision-support model for upper abdominal complaints in primary-care practice.
    Horowitz N; Moshkowitz M; Leshno M; Ribak J; Birkenfeld S; Kenet G; Halpern Z
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1277-83. PubMed ID: 17944742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
    Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
    Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cost-effectiveness analysis of celecoxib versus non-selective non-steroidal anti-inflammatory drug therapy for the treatment of osteoarthritis in Spain: A current perspective].
    De Lossada A; Oteo-Álvaro Á; Giménez S; Oyagüez I; Rejas J
    Semergen; 2016; 42(4):235-43. PubMed ID: 26006311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cost stratification of nonsteroidal anti-inflammatory drug-associated gastrointestinal side effects].
    Lanas A
    Med Clin (Barc); 2000; 114 Suppl 3():46-53. PubMed ID: 10994564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
    Rosengren H; Polson RJ
    Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A trial of a test-and-treat strategy for Helicobacter pylori positive dyspeptic patients in general practice.
    Jones R; Tait C; Sladen G; Weston-Baker J
    Int J Clin Pract; 1999 Sep; 53(6):413-6. PubMed ID: 10622066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the clinical efficacy and cost effectiveness of direct access endoscopy.
    Broe M; Barry M; Patchett S; Hill AD
    Surgeon; 2013 Dec; 11(6):304-8. PubMed ID: 23510705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care.
    Counterweight Project Team
    J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.
    Musumba C; Jorgensen A; Sutton L; Van Eker D; Moorcroft J; Hopkins M; Pritchard DM; Pirmohamed M
    Aliment Pharmacol Ther; 2012 Jul; 36(1):48-56. PubMed ID: 22554233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review article: gastro-oesophageal reflux disease--the health economic implications.
    Mason J; Hungin AP
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():20-31. PubMed ID: 16042656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract.
    Lanas A
    Aliment Pharmacol Ther; 2004 Aug; 20(3):321-31. PubMed ID: 15274669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost, benefits and unintended gastrointestinal side effects of pharmaceutical therapy.
    Bloom BS
    Pharmacoeconomics; 1992 Mar; 1(3):175-81. PubMed ID: 10150155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
    Gralnek IM; Dumonceau JM; Kuipers EJ; Lanas A; Sanders DS; Kurien M; Rotondano G; Hucl T; Dinis-Ribeiro M; Marmo R; Racz I; Arezzo A; Hoffmann RT; Lesur G; de Franchis R; Aabakken L; Veitch A; Radaelli F; Salgueiro P; Cardoso R; Maia L; Zullo A; Cipolletta L; Hassan C
    Endoscopy; 2015 Oct; 47(10):a1-46. PubMed ID: 26417980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.
    Klok RM; Arents NL; de Vries R; Thijs JC; Brouwers JR; Kleibeuker JH; Postma MJ
    Clin Ther; 2005 Oct; 27(10):1647-57. PubMed ID: 16330302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulary management of antiulcer drugs: economic considerations.
    Tucker PP; Nash DB
    Pharmacoeconomics; 1994 Apr; 5(4):313-34. PubMed ID: 10147240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori and non-malignant diseases.
    Kupcinskas L; Malfertheiner P
    Helicobacter; 2005; 10 Suppl 1():26-33. PubMed ID: 16178968
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.